EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Selecting and Preparing Clinical Sites for the Successful Conduct of Decentralized Clinical Trial Activities–Findings From the Trials@Home RADIAL Proof‐of‐Concept Trial

Katarzyna Lipinska, Danny van Weelij iD, Bart Lagerwaard iD, Linda Rutgrink iD, Eduard Vardianu, Petra Naster, Lina Pérez-Breva, Paul Bodfish, Megan Heath iD, Yvonne van Rijswick, Diederick E Grobbee iD, Mira G P Zuidgeest iD und 1 weitere

Clinical Pharmacology & Therapeutics · 2025-11 · 118 (5) · 1057-1066

DOI: 10.1002/cpt.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025-10. Verfasst von Katarzyna Lipinska und 12 weiteren Autor:innen. Beteiligte Einrichtung: Julius Clinical Research, Zeist, The Netherlands. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Decentralized clinical trials (DCTs) offer opportunities to improve trial accessibility, participant convenience, and efficiency, yet may pose significant operational challenges for clinical trial sites. This paper presents the operational insights gained from selecting, training, and supporting clinical sites within the RADIAL proof‐of‐concept trial, part of the Trials@Home project. RADIAL was a multicenter, low‐intervention phase IV trial comparing conventional, hybrid, and fully decentralized approaches for individuals with type 2 diabetes mellitus across six European countries. Site selection involved detailed feasibility assessments evaluating operational capabilities, recruitment potential, technological readiness, and willingness to implement decentralized elements. Despite proactive training, including ongoing support via a centralized helpdesk, sites faced initial difficulties with technology management and participant onboarding. Contractual complexities were prominent, particularly regarding clearly delineating responsibilities and data handling in agreements involving third‐party providers. Moreover, integrating third‐party services necessitated meticulous oversight strategies and continuous stakeholder coordination to ensure regulatory compliance and efficient trial management. Our experiences underscore essential considerations for future DCT implementations: proactive stakeholder alignment; tailored, timely, and ongoing training and support; intuitive technology design informed by clinical user input; robust, centralized oversight structures; and clearly defined delegation frameworks for third‐party engagements. Addressing these operational considerations will facilitate smoother transitions toward decentralized clinical research models, maximizing their potential benefits while managing associated complexities effectively—especially for clinical site staff.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicDiabetes Mellitus, Type 2HumansEuropeMulticenter Studies as TopicProof of Concept Study

Autor:innen und Institutionen

  • Julius Clinical Research, Zeist, The Netherlands.
  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Sanofi, Amsterdam, The Netherlands.
  • Fortrea, Bucharest, Romania.
  • Vital Transformation, Wezembeek-Oppem, Belgium.
  • Vaccine Research FISABIO-Public Health, Valencia, Spain.

ORCID-Profile: Danny van Weelij, Bart Lagerwaard, Linda Rutgrink, Megan Heath, Diederick E Grobbee, Mira G P Zuidgeest

Zitieren

APA

Lipinska, K., van Weelij, D., Lagerwaard, B., Rutgrink, L., Vardianu, E., Naster, P., Pérez-Breva, L., Bodfish, P., Heath, M., van Rijswick, Y., Grobbee, D. E., Zuidgeest, M. G. P., & Trials@Home consortium (2025). Selecting and Preparing Clinical Sites for the Successful Conduct of Decentralized Clinical Trial Activities–Findings From the Trials@Home RADIAL Proof‐of‐Concept Trial. Clinical Pharmacology & Therapeutics, 118(5), 1057-1066. https://doi.org/10.1002/cpt.70075

Vancouver

Lipinska K, van Weelij D, Lagerwaard B, Rutgrink L, Vardianu E, Naster P, et al. Selecting and Preparing Clinical Sites for the Successful Conduct of Decentralized Clinical Trial Activities–Findings From the Trials@Home RADIAL Proof‐of‐Concept Trial. Clinical Pharmacology & Therapeutics. 2025;118(5):1057-1066. doi:10.1002/cpt.70075

BibTeX
@article{Lipinska2025,
  author = {Lipinska, Katarzyna and van Weelij, Danny and Lagerwaard, Bart and Rutgrink, Linda and Vardianu, Eduard and Naster, Petra and Pérez-Breva, Lina and Bodfish, Paul and Heath, Megan and van Rijswick, Yvonne and Grobbee, Diederick E and Zuidgeest, Mira G P and Trials@Home consortium, Trials@Home consortium},
  title = {Selecting and Preparing Clinical Sites for the Successful Conduct of Decentralized Clinical Trial Activities–Findings From the Trials@Home RADIAL Proof‐of‐Concept Trial},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  volume = {118},
  number = {5},
  pages = {1057--1066},
  doi = {10.1002/cpt.70075}
}
Kostenlos starten →